Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced that analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) will be ...

Singapore-based AscenZion Neuromodulation Co announced the publication of a significant paper on the ‘Effect of transcranial pulsed current stimulation on social functioning in children with autism’ ...

Cuts and layoffs to the National Institutes of Health threaten medical research around the U.S., agency insiders warn.

Former National Institutes of Health Director Dr. Francis Collins, who abruptly left his NIH research lab in February, fears ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Patterns of mortality and end-of-life care have changed among US ischemic stroke patients, with increases in mortality seen across all urbanization levels.

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Neurological disorders, including neurodegenerative diseases, brain tumors, and other conditions like stroke and epilepsy, increasingly burden healthcare ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other hand, the loss of function in certain kinases has been identified as a ...